重庆啤酒的治疗用(合成肽)乙型肝炎疫苗(以下简称乙肝疫苗)实验结果存疑,引发了巨大的震动,部分投资者损失惨重,公众将眼光投向了研发的全过程,本文简单回顾了事件的过程,并着指出了重庆啤酒在信息披露中存在的问题,分析了问题产生的原因,对企业研发项目的信息披露提出了自己的改进建议。 Chongqing (Hepatitis B vaccine for treatment of synthetic peptide) (hereinafter referred to as hepatitis B vaccine) experimental results doubt, triggering a huge shock, some investors suffered heavy losses, the public will look into the whole process of research and development, this article briefly reviewed the incident The paper also points out the problems existing in the information disclosure of Chongqing Beer, analyzes the causes of the problems, and puts forward some suggestions for improving the information disclosure of the R & D projects in the enterprises.